Welcome to CCST


CCST provides excellent world class research facilities and the expertise to perform early Phase I and II studies for the pharmaceutical industry. Since the late 1990’s CCST has become a major provider of clinical trials to the pharmaceutical industry.


CCST undertakes medical research in many therapeutic areas .  We conduct clinical studies which involve healthy people as well as specific disease groups.  To take part in a clinical study at CCST you need to register. Register Here.


Christchurch doctors have, over many years, been involved in a wide range of clinical trials for the pharmaceutical industry. A need was identified for a well designed and dedicated facility to perform Phase I and II pharmacokinetic and pharmacodynamic studies in healthy volunteer and patient populations.

Current Studies

Upcoming Studies  


Healthy Males and women of non child bearing potential

Age 18 to 60 Years

General Health Healthy, non smokers, no medications

Requirements Short inpatient stays and follow up appointments Single dose of study drug. 3 night in-house stay and 12 clinic visits

Read more


Post-Menopausal Females

Age: 45 to 70 years

Healthy (study has some medication restrictions) Non smokers.

Study addressing the issue of muscle weakness and its role in falls.

Requirements:  A dose of study drug.  2-night in-house stay, 7 clinic visits.

Compensation:  $3600 (less tax)



Healthy Male and Post menopausal or surgically sterile Females wanted

 Age 18 – 55 years

Gender Males and Post menopausal or surgically sterile Females

General Health Healthy, non smokers

Overall Status Recruiting

Study Type Safety and Tolerability of an anti viral medication

Requirements 3 night in-house stay and 5 clinic visit over a 2 week period

Compensation $2800 (less tax)



Age 18 to 40 Years
Gender Females due to give birth between 20 March and 11 July 2017
General Health Healthy women having a single baby and have less than 5 children

This trial is being run in conjunction with the University of Otago and Christchurch Women’s Hospital.  We are investigating how well a new vaccine given to mothers may protect babies from illness due to respiratory syncytial virus (RSV) in their first six months of life.

Text RSV to 8808


Contact Us

Do not hesitate to contact Us!


0800 TO CCST or +64 3 372 9477


+64 3 3729478



CCST needs people to participate in our clinical research

CCST provides world class research facilities and expertise